Methenamine hippurate microbiology

Revision as of 14:59, 9 January 2014 by Abdurahman Khalil (talk | contribs) (Created page with "__NOTOC__ {{Methenamine hippurate}} {{CMG}}; {{AE}} {{AK}} Methenamine hippurate USP has antibacterial activity because the methenamine component is hydrolyzed to formaldehyd...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Methenamine hippurate
HIPREX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Methenamine hippurate USP has antibacterial activity because the methenamine component is hydrolyzed to formaldehyde in acid urine. Hippuric acid, the other component, has some antibacterial activity and also acts to keep the urine acid. The drug is generally active against E. coli, enterococci and staphylococci. Enterobacter aerogenes is generally resistant. The urine must be kept sufficiently acid for urea-splitting organisms such as Proteus and Pseudomonas to be inhibited


References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/17681s014lbl.pdf